Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8545 | 1173 | 41.6 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EOTAXIN | Author keyword | 69 | 38% | 12% | 145 |
2 | CCR3 | Author keyword | 37 | 46% | 5% | 61 |
3 | RANTES | Author keyword | 18 | 15% | 9% | 107 |
4 | EOTAXIN 2 | Author keyword | 16 | 61% | 1% | 17 |
5 | CCR3 ANTAGONISTS | Author keyword | 11 | 100% | 1% | 6 |
6 | EOTAXIN 2 CCL24 | Author keyword | 11 | 100% | 1% | 6 |
7 | MONOCYTE CHEMOTACTIC PROTEINS | Author keyword | 8 | 100% | 0% | 5 |
8 | EOTAXIN 3 | Author keyword | 7 | 36% | 1% | 16 |
9 | EOTAXIN CCL11 | Author keyword | 7 | 57% | 1% | 8 |
10 | CCR 3 | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EOTAXIN | 69 | 38% | 12% | 145 | Search EOTAXIN | Search EOTAXIN |
2 | CCR3 | 37 | 46% | 5% | 61 | Search CCR3 | Search CCR3 |
3 | RANTES | 18 | 15% | 9% | 107 | Search RANTES | Search RANTES |
4 | EOTAXIN 2 | 16 | 61% | 1% | 17 | Search EOTAXIN+2 | Search EOTAXIN+2 |
5 | CCR3 ANTAGONISTS | 11 | 100% | 1% | 6 | Search CCR3+ANTAGONISTS | Search CCR3+ANTAGONISTS |
6 | EOTAXIN 2 CCL24 | 11 | 100% | 1% | 6 | Search EOTAXIN+2+CCL24 | Search EOTAXIN+2+CCL24 |
7 | MONOCYTE CHEMOTACTIC PROTEINS | 8 | 100% | 0% | 5 | Search MONOCYTE+CHEMOTACTIC+PROTEINS | Search MONOCYTE+CHEMOTACTIC+PROTEINS |
8 | EOTAXIN 3 | 7 | 36% | 1% | 16 | Search EOTAXIN+3 | Search EOTAXIN+3 |
9 | EOTAXIN CCL11 | 7 | 57% | 1% | 8 | Search EOTAXIN+CCL11 | Search EOTAXIN+CCL11 |
10 | CCR 3 | 6 | 80% | 0% | 4 | Search CCR+3 | Search CCR+3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EOTAXIN RECEPTOR | 47 | 54% | 5% | 61 |
2 | CHEMOKINE RECEPTOR CCR3 | 45 | 65% | 4% | 43 |
3 | EOSINOPHIL CHEMOATTRACTANT CYTOKINE | 40 | 77% | 2% | 27 |
4 | CYTOKINE RANTES | 32 | 37% | 6% | 69 |
5 | EOSINOPHIL EOTAXIN RECEPTOR | 27 | 66% | 2% | 25 |
6 | RECEPTOR CCR3 | 27 | 49% | 3% | 40 |
7 | TISSUE EOSINOPHILIA | 25 | 25% | 7% | 86 |
8 | EOTAXIN | 23 | 23% | 8% | 89 |
9 | CHEMOATTRACTANT CYTOKINE | 23 | 76% | 1% | 16 |
10 | HUMAN CC CHEMOKINE | 18 | 45% | 3% | 30 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Eotaxin and eosinophil recruitment: implications for human disease | 2000 | 136 | 58 | 79% |
Chemokines in asthma: Cooperative interaction between chemokines and IL-13 | 2003 | 175 | 124 | 40% |
Human chemokines: An update | 1997 | 1658 | 178 | 21% |
Eotaxin and the attraction of eosinophils to the asthmatic lung | 2001 | 69 | 59 | 86% |
Role of chemokines in the pathogenesis of asthma | 2001 | 155 | 106 | 45% |
Recent developments in CCR3 antagonists | 2006 | 24 | 30 | 73% |
CCL chemokines and asthma | 2000 | 88 | 41 | 76% |
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases | 2004 | 55 | 100 | 42% |
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4 | 2014 | 6 | 125 | 26% |
From airway inflammation to inflammatory bowel disease: Eotaxin-1, a key regulator of intestinal inflammation | 2014 | 2 | 99 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMBINED PROGRAM PULM CRIT CARE MED | 4 | 36% | 0.8% | 9 |
2 | BIOREGULATORY FUNCT | 4 | 17% | 1.8% | 21 |
3 | LEUKOCYTE BIOL SECT | 4 | 11% | 2.5% | 29 |
4 | IPF PHARMACEUT GMBH | 3 | 60% | 0.3% | 3 |
5 | PULM MED ALLERGY CLIN IMMUNOL | 2 | 19% | 0.7% | 8 |
6 | SECT PATHOL IMMUNOL | 1 | 38% | 0.3% | 3 |
7 | AN HANNOVER MED | 1 | 100% | 0.2% | 2 |
8 | INTERNAL MED PNEUMONOL ALLERGOL | 1 | 19% | 0.5% | 6 |
9 | ASTHMA GENOME GRP | 1 | 25% | 0.3% | 3 |
10 | ANTOINE BECLERE TEACHING HOSP | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000289925 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
2 | 0.0000283388 | THYMUS AND ACTIVATION REGULATED CHEMOKINE//TARC//CCR4 |
3 | 0.0000263989 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
4 | 0.0000191335 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION |
5 | 0.0000170890 | LYMPHOTACTIN//CTAP III//CHEMOKINE STRUCTURE |
6 | 0.0000158464 | EOSINOPHILS//EOSINOPHIL//TUMOR ASSOCIATED TISSUE EOSINOPHILIA |
7 | 0.0000137162 | INTERLEUKIN 5//IL 5//INTERLEUKIN 5 RECEPTOR |
8 | 0.0000127203 | CCL20//CCR6//MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA |
9 | 0.0000109394 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |
10 | 0.0000101751 | CXCR2//CXCR1//G31P |